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Within the Burkholderia cepacia complex, B. cenocepacia is the most common species associated with aggres-
sive infections in the lungs of cystic fibrosis patients, causing disease that is often refractive to treatment by
antibiotics. Phage therapy may be a potential alternative form of treatment for these infections. Here we
describe the genome of the previously described therapeutic B. cenocepacia podophage BcepIL02 and its close
relative, Bcep22. Phage Bcep22 was found to contain a circularly permuted genome of 63,882 bp containing 77
genes; BcepIL02 was found to be 62,714 bp and contains 76 predicted genes. Major virion-associated proteins
were identified by proteomic analysis. We propose that these phages comprise the founding members of a novel
podophage lineage, the Bcep22-like phages. Among the interesting features of these phages are a series of
tandemly repeated putative tail fiber genes that are similar to each other and also to one or more such genes
in the other phages. Both phages also contain an extremely large (ca. 4,600-amino-acid), virion-associated,
multidomain protein that accounts for over 20% of the phages’ coding capacity, is widely distributed among
other bacterial and phage genomes, and may be involved in facilitating DNA entry in both phage and other
mobile DNA elements. The phages, which were previously presumed to be virulent, show evidence of a
temperate lifestyle but are apparently unable to form stable lysogens in their hosts. This ambiguity complicates
determination of a phage lifestyle, a key consideration in the selection of therapeutic phages.
Bacteria of the genus Burkholderia constitute an ecologically
and metabolically diverse group of organisms, which includes
soil saprophytes, nitrogen-fixing rhizosphere inhabitants, bio-
logical control agents, and species that are pathogenic to
plants, animals, and humans (14). Within this genus, the Burk-
holderia cepacia complex is currently comprised of at least 17
bacterial species, including several species recognized as op-
portunistic human pathogens capable of infecting immuno-
compromised individuals (50, 85). Especially at risk from B.
cepacia complex infections are individuals with cystic fibrosis
(CF) or chronic granulomatous disease. While all members of
the B. cepacia complex have been associated with infections in
the lungs of CF patients, B. cenocepacia is the most common
member associated with persistent and aggressive infections in
these patients, causing necrotizing pneumonia, sepsis, and
death. Clinical outcomes of B. cenocepacia infections in CF
patients are typically poor, and this bacterium is often innately
resistant to many chemical antibiotics. The severity of these
infections, coupled with the current lack of available effective
treatments, has ignited interest in the development of alterna-
tive treatment options.
The use of bacteriophages for the treatment of bacterial
infections, a practice commonly termed phage therapy, is an
old idea, first proposed by the phage codiscoverer Felix
d’Herelle (78). While phage therapy was largely abandoned in
the West with the discovery of chemical antibiotics, the prac-
tice continued in the former Soviet Union and its satellite
states and is still used routinely today in these regions as an
adjunct to antibiotics in human medicine (72). Phage therapy
has been a topic of increasing research in the West over the
past several years, as new bacterial pathogens have emerged,
antimicrobial resistance in important human pathogens has
become more widespread, and the development pipelines for
novel small-molecule antimicrobials have largely run dry (63).
Phages that have utility as potential therapeutic agents should
meet at least two minimal criteria: they should be virulent
(unable to form lysogens that would then be insensitive to
further phage infections) and they must target the specific
strains of the pathogen that they are intended to treat. While
determination of the latter is relatively straightforward, the
issue of phage virulence is not always clear. By its nature, a
temperate lifestyle is easy to prove (by isolation of stable ly-
sogens) but not as easily disproven, as failure to establish
lysogeny is not conclusive proof of virulence.
A number of phages capable of infecting clinically relevant
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members of the B. cepacia complex have been characterized,
and some have also been sequenced. Several of these phages,
such as NS1 and NS2 (57), DK1 and DK3 (41), KS4 and KS9
(71), BcepMu (77), and KS10 (22), were isolated from super-
natants of lysogenic bacteria and are therefore temperate
phages. Based on their genome organization, the environmen-
tally isolated phages Bcep781, Bcep1, Bcep43, and BcepB1A
have been reported to be virulent phages (76). However, while
these phages appear to possess the desired characteristic of
virulence, they were not isolated on Bcc strains that are clini-
cally relevant for purposes of phage therapy. Recent work has
shown that a lysogeny-defective mutant of the BcepMu-like
KS4, the temperate phage KS14, and the less-well-character-
ized phage KS12 reduced B. cepacia complex-induced mortal-
ity in a wax worm model (70). A repressorless virulent mutant
of phage KS9 has also been shown to reduce mortality in this
model (49). Here we describe two related B. cepacia complex
phages, Bcep22 and BcepIL02. Both phages are able to infect
pathogenic clinical isolates of B. cenocepacia, and one of them,
BcepIL02, has been shown to reduce the colonization of patho-
genic B. cenocepacia in a mouse lung model (10).
MATERIALS AND METHODS
Strains and culture conditions. Phage Bcep22 was isolated from soil collected
in the summer of 2000 from Orange County, NY, by enrichment against a B.
cenocepacia strain (S198C28A) isolated from the same soil sample. Phage Bce-
pIL02 was isolated from a corn field soil sample in Champaign County, IL, in the
summer of 2006, as described previously (10). B. cenocepacia strains were rou-
tinely cultured aerobically at 37°C on tryptone nutrient broth (TNB; 8.5 g/liter
NaCl, 1 g/liter glucose, 5 g/liter tryptone, 2.5 g/liter yeast extract) or tryptone
nutrient agar (TNA; TNB amended with 15 g/liter Bacto agar). Phages Bcep22
and BcepIL02 were routinely cultured at 37°C on B. cenocepacia strains AU1054
and PC184, respectively, using TNA plates and overlays of TNA soft agar (TNB
amended with 5 g/liter Bacto agar) and standard culture techniques (1). Small-
volume phage lysates were harvested from TNA soft agar overlays displaying
nearly confluent lysis by flooding plates with SM buffer (50 mM Tris-HCl [pH
7.5], 100 mM NaCl, 8 mM MgSO4, 0.01% [wt/vol] gelatin), aspirating the result-
ing soft agar slurry, centrifuging (10,000  g, 10 min, 4°C), and sterilizing by
passage through a 0.22-m syringe filter (Millipore, Billerica, MA). For lysogen
formation assays (see below), plate lysates were harvested in LB broth (10 g/liter
tryptone, 5 g/liter yeast extract, 10 g/liter NaCl) instead of SM buffer. Large-scale
phage lysates for proteomic analysis were prepared by inoculating 2 liters of TNB
with the appropriate bacterial host to a final optical density at 550 nm (OD550)
of 0.05, adding phage to a final multiplicity of infection (MOI) of 0.025, and
incubating at 37°C with vigorous aeration. When the culture was determined to
have mostly lysed (as determined by monitoring the OD550) after 10 to 12 h, the
lysate was harvested by shaking for 10 min in the presence of 0.5% (vol/vol)
CHCl3, centrifugation (12,000  g, 15 min, 4°C), and retention of the clarified
supernatant.
Genome sequencing and annotation. Phage genomic DNA was prepared from
filter-sterilized plate lysates with the Wizard DNA cleanup kit (Promega, Mad-
ison, WI) using a modified protocol (73). Phage Bcep22 was sequenced to
8-fold coverage by dideoxy termination sequencing as described previously
(77). Phage BcepIL02 was sequenced to 23-fold coverage by 454 pyrosequencing
at a commercial facility (Roche/454 Life Sciences, Branford, CT). Gap closure
was completed by amplification of gap regions by PCR followed by dideoxy
termination sequencing of the products. Completed DNA sequences were ana-
lyzed for potential protein-coding genes with Genemark.hmm (48), and the
predicted coding regions were manually refined in Artemis (66). Protein se-
quences were compared to the NCBI protein database by using BLASTp (9);
tRNA genes were detected with tRNAscan (68); rho-independent terminators
were detected with TransTerm HP (37); promoters were detected using BPROM
(Softberry). Potential functional domains within proteins were determined by
analysis with the stand-alone InterProScan suite version 4.7 run locally (29).
Protein localization was predicted by use of SignalP 3.0 (6), LipoP 1.0 (33), and
TMHMM (http://www.cbs.dtu.dk/services/TMHMM). Phage genome maps were
rendered with DNA Master (http://cobamide2.bio.pitt.edu/computer.htm). Pair-
wise protein sequence similarities were calculated by the Dice method, using
BLASTp determinations of amino acid identity.
Proteomic analysis. Phages were purified for proteomic analysis by two rounds
of banding in a CsCl gradient, based on previously described methods (42, 67).
Phage was then dialyzed thoroughly against gelatin-free SM buffer and concen-
trated further using a 100-kDa molecular weight cutoff Amicon ultrafiltration
unit (Millipore). Phage proteins were analyzed by SDS-PAGE by boiling purified
phage for 5 min in Laemmli sample buffer (62.5 mM Tris-HCl [pH 6.8], 2% SDS,
10% glycerol, 5% -mercaptoethanol, 0.001% bromophenol blue), and the
equivalent of 3  1010 PFU was loaded per lane on a 10% SDS-PAGE gel by
standard methods (40). Coomassie-stained bands were excised and subjected to
reduction using dithiothreitol and alkylation with iodoacetamide followed by
tryptic digestion carried out robotically using a ProGest robotic device (Genomic
Solutions, Ann Arbor, MI) suited for automated digestion protocols and tem-
perature-controlled reactions. The resulting tryptic peptides were concentrated
and desalted using C18 ZipTips (Millipore) and spotted robotically directly onto
a matrix-assisted laser desorption ionization (MALDI) target (Genomic Solu-
tions) using a 7.5-mg/ml solution of -cyano 4-hydroxycinnamic acid (CHCA).
Additionally, phage proteins were subjected to liquid chromatography-MALDI-
tandem mass spectrometry (LC-MALDI-MS/MS) analysis. Phage samples were
denatured in 6 M urea and 1 mM dithiothreitol (DTT; Sigma) and subjected to
5 freeze-thaw cycles between a dry ice-ethanol bath and a 37°C heat block. The
samples were centrifuged at 14,000 rpm for 10 min, and the supernatant was
subjected to solution-phase tryptic digestion. Briefly, 10 mM iodoacetamide was
added to the protein solution followed by addition of trypsin at a 1:50 (wt/wt)
ratio and incubated at 37°C overnight. Approximately 1 g of the tryptic diges-
tion solution was further separated by loading onto a trap column (300 m by 1
cm; C18 PepMap) coupled with a Vydac (150 m by 15 cm; C18) analytical
column, and chromatography was carried out using an LC Packings Ultimate
system (Dionex). The eluent from the analytical column was spotted robotically
onto the MALDI target via a ProBot (LC Packings) as described previously (65).
MALDI-MS and MS/MS analysis were carried out on a model 4700 Proteom-
ics Analyzer (Applied Biosystems). For both the gel-based method and the
LC-separated peptides, MS data were acquired from m/z 700 to 4,500, and the
top 10 peaks in each spot were subjected to tandem MS analysis. Spectra were
externally calibrated using bradykinin fragment 2–9 and adrenocorticotropic
hormone fragment 18–39. The resulting spectra were subjected to database
searching using GPS Explorer (Applied Biosystems) with an in-house license of
mascot (v 2.1). MS and MS/MS spectra were used for the in-gel-digested pro-
teins, and only the MS/MS spectra were used for database searching of the
LC-MS/MS analysis results. Spectra were searched against a FASTA file con-
taining the predicted protein products of Bcep22 and BcepIL02.
Proteins were considered to be virion associated if they were identified via
either the whole-virion or the in-gel digestion methods by two or more unique
peptides with ion scores greater than 40, or were identified by 5 or more unique
peptides with deviations from the predicted ion mass of less than 20 ppm.
Identities of low-scoring peptides were manually confirmed by examination of
the raw MS peak output. All identified proteins had total ion score confidence
intervals of greater than 99.5% as calculated with GPS Explorer, taking into
account the mascot score.
Identification of proteins with homotypic interactions. A lambda repressor
fusion library was constructed by fragmentation of Bcep22 DNA by hydroshear,
end repair, and ligation into the vector pLM100 and screened as described
previously (77). In principle, only DNA inserts encoding a protein sequence
capable of complementing the missing C-terminal dimerization domain of the
phage lambda cI repressor in pLM100 would survive subsequent challenge by
phage lambda lacking the cI gene (52). Of the 96 surviving colonies screened, 71
contained inserts encoding an in-frame portion of a predicted Bcep22 gene. Only
Bcep22 genes containing two or more such hits were retained for further analysis.
Isolation of bacteriophage-insensitive mutants. Bacterial cells were harvested
from the surface of four independent overnight plate cultures of strains AU1054
and PC184 and used to inoculate TNB at A550 of 0.1. Phages Bcep22 and
BcepIL02 were added to these cultures, respectively, to a final input MOI of 1,
and these cultures were incubated with aeration for 16 to 18 h at 37°C. Cells
surviving phage coculture were streaked onto TNB plates, and two surviving
colonies showing robust growth in the heaviest, phage-containing part of the
streak were subcultured twice to remove contaminating phage. A total of 16
phage-insensitive strains (8 from strain AU1054 challenged with Bcep22 and 8
from PC184 challenged with BcepIL02) were isolated. Additionally, three strains
of B. cenocepacia AU0728 insensitive to phage BcepIL02 were isolated from
homogenized mouse tissue following treatment of infected mice with this phage
(10).
Phage sensitivity was assessed by applying 10-l spots of serially diluted phage
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(Bcep22 or BcepIL02) to soft agar lawns inoculated with the mutant strains and
comparing the efficiency of plating (EOP) to the plating efficiency of the phage
on its respective wild-type host. Production of phage by the mutant strains was
assayed by removing 0.5-ml aliquots of 16- to 18-h liquid cultures of each strain,
mixing vigorously with 20 l chloroform, and centrifuging at 12,000 g for 1 min
at room temperature (RT). Ten-microliter aliquots of each supernatant were
spotted to lawns of the mutant strain from which it was produced and also to the
respective wild-type host, and lawns were observed for plaque formation.
Assays for lysogen formation. To examine lysogen formation under high-MOI
conditions, overnight cultures of strain PC184 were subcultured 1:50 into fresh
LB broth and cultured with aeration at 37°C to an OD550 of 0.45 to 0.5. Cells
were pelleted by centrifugation (12,000  g, 1 min, RT) and resuspended to a
final OD550 of 1.0 in 0.25 ml of a fresh (2-week-old) phage BcepIL02 lysate
(harvested in LB) or sterile LB. These cell-phage mixtures were incubated for 30
min at RT and then centrifuged as described above. An aliquot of the superna-
tants was removed, serially diluted, and plated to lawns of PC184 to determine
the phage titer remaining following incubation. The remainder of the superna-
tants were removed, and the cell pellets were resuspended in 0.25 ml of sterile
LB. These cells were serially diluted and plated to enumerate the bacterial
survivors remaining following phage exposure. This number of surviving CFU
was compared to the CFU contained in the LB-only control reaction mixtures to
calculate the percentage of bacterial survivors. The postincubation supernatant
titers were compared to the titer of the phage stock to calculate the percentage
of phage adsorbed to cells during the incubation period. From these data, the
actual MOI (MOIactual, the ratio of the number of adsorbed phage to the number
of CFU in the phage-free controls [35]) was calculated. These MOIactual values
were used to calculate the proportions of cells adsorbing no phage, a single
phage, and multiple phage based on a Poisson distribution (1). This experiment
was replicated three times.
Transmission electron microscopy. Phage were applied to thin carbon films
and stained with 2% (wt/vol) uranyl acetate according to the Valentine method
(84). Carbon films were applied to 300-mesh copper grids, air dried, and viewed
in a JEOL 1200 EX transmission electron microscope under 100 kV accelerating
voltage. Five virions of each phage were measured, and these data were used to
calculate mean values and standard deviations.
RESULTS AND DISCUSSION
Overview of Bcep22 and BcepIL02. Bacteriophages Bcep22
and BcepIL02 are both Podoviridae and are nearly identical
morphologically (Fig. 1). Both phages have 70-nm isometric
heads and short, noncontractile tails. No long tail fibers were
observed, but their presence cannot be ruled out, given the
difficulty of visualization of phage tail fibers by negative stain.
Both phages produce clear, 1- to 3-mm-diameter plaques when
plated on their respective hosts on either TNA or LB medium.
Phage BcepIL02 is able to form plaques on both its own host
(B. cenocepacia PC184) and the host of Bcep22 (B. cenocepacia
AU1054) with equivalent efficiency, while Bcep22 forms
plaques only on strain AU1054.
Overview of the genomes of Bcep22 and BcepIL02. The
genome of Bcep22 (GenBank accession number AY349011)
was found to be 63,882 bases in length, with a 65.3% GC
content, a coding density of 94.6%, and containing 77 pre-
dicted protein-coding genes and one predicted serine tRNA
gene. The genome of BcepIL02 (GenBank accession number
FJ937737) was determined to be 62,714 bases in length, with a
66.2% GC content, a coding density of 95.2%, and contain-
ing 76 predicted protein-coding genes and one predicted serine
tRNA gene. The GC contents of phages Bcep22 and
BcepIL02 are both similar to that of B. cenocepacia, which
possesses a 66.9% GC content (28). Based on restriction
maps of phage genomic DNA and the assembly of individual
reads from the Bcep22 clone library, the genomes of both
phages appeared to be circularly permuted. The genome se-
quences were therefore arbitrarily opened immediately after
the predicted lysis cassettes.
The genomes of Bcep22 and BcepIL02 were found to be
diverged while retaining overall synteny (Fig. 2). Pairwise
DNA MegaBLAST analysis of the two genomes produced
sequence alignments over 69.8% of the phage genomes, with
89.0% similarity between the two phages in these aligned re-
gions at the DNA level. The phages contain 51 homologous
genes that possess amino acid similarities ranging from 15% to
98% (Fig. 2; Table 1). In addition to these, each phage genome
contains a set of redundant predicted tail fiber-encoding genes
(three in Bcep22, four in BcepIL02), which are similar to each
other and also to one or more such genes in the other phages
(Fig. 3). Edited BLASTp results for all phage proteins are
available in Tables S1 and S2 of the supplemental material.
Proteomic analysis and virion-associated proteins. Pro-
teomic analysis was conducted on CsCl-purified virions of both
Bcep22 and BcepIL02 by using dual approaches: whole-virion
digestion followed by LC-MALDI analysis, and MALDI anal-
ysis of digested SDS-PAGE species. In BcepIL02, 16 proteins
were identified as virion associated by one or both methods
(Table 2). In Bcep22, eight proteins were directly detected and
an additional five proteins were inferred to be virion associated
based on the detection of a homologous protein in BcepIL02
(Table 2).
For both phages, the most abundant virion protein, as
judged by SDS-PAGE, was an 40-kDa species, in agreement
with the predicted 40-kDa masses of the putative major capsid
proteins, gp55 of Bcep22 and gp50 of BcepIL02 (data not
shown). No other bands could be determined by MALDI anal-
ysis to be cleavage products of these proteins. Peptides corre-
sponding to residues 2 to 12 (SSTVIPFGDSK) and 350 to 361
(DFGVISIDTAAK) of the 364-amino-acid BcepIL02 putative
major capsid protein gp50 were detected by the LC-MALDI
method, indicating that a full-length version of this protein is
assembled into the virion structure following cleavage of the
N-terminal methionine by the general methionine aminopep-
tidase.
Identification of proteins with homotypic interactions. Sev-
enty clones containing homotypically interacting lambda re-
FIG. 1. Transmission electron micrographs of phages Bcep22
(A) and BcepIL02 (B). Samples were stained with 2% (wt/vol) uranyl
acetate and observed at 100 kV. Bcep22 was observed to have a capsid
diameter of 71 nm (1.5 nm) and a short, noncontractile tail measur-
ing 15 nm (2.3 nm) in length and 14 nm (1.7 nm) in width. The
capsid of BcepIL02 was determined to be 72 nm (2.6 nm) in diameter
with a tail of 18 nm (2.0 nm) in length and 15 nm (1.0 nm) in width.
The differences in dimensions between the two phages were deter-
mined to be not statistically significant based on the t test (P  0.05).
Bars, 100 nm.
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pressor fusions were identified, matching various regions of 15
Bcep22 proteins ranging from 12 matches to Bcep22 gp39 to
two matches against gp10, gp13, gp19, gp27, gp37, and gp44
(Fig. 4). Of these 15 proteins, 10 are either conserved or
hypothetical novel proteins with no known function, although
one of these, gp68, was found to be virion associated. Of the
remaining five proteins, all have predicted functions associated
with a multimeric state, thereby strengthening their functional
predictions, and also have homologs present in BcepIL02 (Ta-
ble 1). Bcep22 gp10 is predicted to function as a RecT-like
recombination strand invasion protein, working in concert with
the gp11 RecB-like nuclease as the functional equivalent of the
Escherichia coli RecE/RecT or coliphage lambda Red/Red
systems (25, 56) and expected to form multimeric complexes
on single-stranded DNA. Bcep22 gp13, a putative transcrip-
tional regulator, appears to be capable of oligomerization via
its C terminus (Fig. 4), suggesting it has similar architecture to
the lambda cI repressor, which contains an N-terminal DNA-
binding domain and a C-terminal dimerization domain (3).
This finding further supports the annotation of gp13 (and by
extension, BcepIL02 gp8) as cI-like dimerizing repressors, as
the Bcep22 gp13 C terminus is effectively able to complement
the lambda cI C-terminal domain. The Bcep22 gp13 putative
transcriptional regulator could possibly function as a lysogenic
repressor.
Bcep22 gp27, predicted to be a replication initiation protein,
was found to possess a self-interacting domain in its N termi-
nus (Fig. 4). This is consistent with the behavior of other
initiation proteins, such as E. coli DnaA, which oligomerizes
via its N-terminal domain (34). Bcep22 gp44 is also predicted
to function as a transcriptional regulator, due to the presence
of a helix-turn-helix (HTH) DNA-binding domain (IPR001387).
Unlike gp13, gp44 appears to lack a cI-like C-terminal dimeriza-
tion domain, but it may be able to form dimers on its own in a
manner similar to other small, HTH domain repressors, such as
lambda Cro (80). Finally, the Bcep22 gp64 putative tail fiber was
found to homotypically interact across a broad section of its C
terminus. This finding is not unexpected for a putative tail fiber
protein, as phage tail fibers commonly form trimers prior to as-
sembly into the virion (45). It is not clear, however, why only one
of the three putative tail fiber orthologs found in Bcep22 was
detected in this assay. Bcep22 gp64 is highly diverged in its C
terminus from the other tail fibers in both Bcep22 and BcepIL02
(Fig. 3), suggesting that this more-atypical sequence possesses
self-assembly properties lacking in the other tail fiber orthologs.
Relationships to other phages. While Bcep22 and BcepIL02
were found to be highly related to one another, these phages
are not clearly members of any of the currently designated
phage lineages, nor are they closely related to other previously
sequenced phages. A published analysis of Podoviridae taxon-
omy based on protein sequence relatedness was unable to
reliably group Bcep22 with any other sequenced podophages
(44).
Phage Bcep22 will be used for presentation of broader in-
terorganism analyses, as it is the founder of the Bcep22-like
phage type. The genomes with the closest relationship to the
Bcep22-like phages described here are those of an unnamed
draft plasmid in Ochrobactrum intermedium LMG 3301
(ACQA01000004), and Sinorhizobium meliloti phage PBC5
(AF448724), a phage of undetermined morphology and life-
FIG. 2. Comparative genomic maps of phages Bcep22 and BcepIL02. Predicted genes are represented by boxes above and below the heavy
black line for each phage genome; boxes above the lines are genes encoded on the forward strand, and those below the lines are on the reverse
strand. The ruler below the genomes indicates the scale (in kb). Genome features (conserved, hypothetical novel, and virion-associated proteins;
tRNA genes; rho-independent terminators) are color coded according to the legend below the ruler. Protein similarity is denoted by colored bars
between genome maps, with colors indicating the percent relatedness according to the legend at the bottom of the figure; similarity of less than
20% is not shown on this map. Selected genes and gene modules are annotated based on predicted function.
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TABLE 1. Comparative annotations of Burkholderia phages Bcep22 and BcepIL02a
Phage Bcep22
% protein
identity
Phage BcepIL02
Putative function Calculated mass(kDa) Gene name Gene name
Calculated mass
(kDa) Putative function
Conserved protein 18.3 1 1 22.7 Hypothetical novel
Conserved protein 12.6 2 2 7.1 Hypothetical novel
Conserved protein 9.8 3 3 43.5 Conserved protein
Hypothetical novel 7.5 4 4 47.7 Tyrosine recombinase
Conserved protein 36.0 5 5 4.3 Hypothetical novel
Serine recombinase 61.1 6
Conserved protein 8.8 7
Hypothetical novel 5.7 8
Hypothetical novel 14.0 9
RecT-like protein 37.4 10 90.7 6 37.8 RecT-like protein
Nuclease/RecB-like protein 38.4 11 96.8 7 38.5 Nuclease/RecB-like protein
Transcriptional regulator 21.4 13 76.7 8 19.3 Transcriptional regulator
Conserved protein 12.8 14 55.9 9 14.2 Conserved protein
HNH endonuclease 18.7 15 10 13.5 Conserved protein
HNH endonuclease 28.5 16 11 31.0 Conserved DUF2303 protein
12 9.5 Hypothetical novel
SSB protein 18.7 17 83.9 13 19.3 SSB protein
Conserved protein 7.9 18 76.4 14 8.1 Conserved protein
Conserved protein 16.8 19 38.9 15 18.0 Conserved protein
Conserved protein 18.1 20 86.1 16 18.0 Conserved protein
Conserved protein 9.7 21 96.7 17 9.7 Conserved protein
Hypothetical novel 19.2 22
Conserved protein 17.0 23 85.0 18 16.1 Conserved protein
Conserved protein 8.6 24 89.7 19 8.6 Conserved protein
Methyltransferase 39.7 25
Replication protein 28.7 27 51.0 20 30.6 Replication protein
DnaC-like helicase loader 30.4 28 87.9 21 30.4 DnaC-like helicase loader
22 15.2 PagP-like OMP
Conserved protein 6.3 29 44.0 23 4.6 Conserved protein
Conserved protein 15.2 30 24 10.8 Hypothetical novel
25 11.4 Hypothetical novel
Conserved protein 44.8 31 64.5 26 45.5 Conserved protein
Transposase, ISL3 family 55.3 32
Conserved protein 14.1 33
Conserved protein 7.4 34
Conserved protein 20.6 35 76.4 27 20.3 Conserved protein
Terminase small subunit 28.7 36 52.4 28 30.3 Terminase small subunit
29 13.2 Hypothetical novel
30 28.9 Hypothetical novel
31 19.0 Hypothetical novel
Conserved protein 16.6 37 43.9 32 15.7 Conserved protein
Conserved protein 11.5 38 56.0 33 11.2 Conserved protein
Conserved protein 7.5 39
Conserved protein 7.7 40 64.7 34 7.8 Conserved protein
Conserved protein 6.9 41 85.3 35 7.3 Conserved protein
36 6.6 Hypothetical novel
Conserved protein 5.2 42 59.1 37 5.5 Conserved protein
Hypothetical novel 5.8 43
Transcriptional regulator 7.9 44 90.3 38 7.9 Transcriptional regulator
Conserved protein 7.2 45 72.6 39 7.5 Conserved protein
Conserved protein 5.4 46 44.1 40 6.8 Conserved protein, Sec signal
Hypothetical novel 7.2 47 41 35.1 Methyltransferase
Conserved protein 14.6 48 42 23.0 Type II restriction endonuclease
43 29.5 DNA ligase
Terminase large subunit 60.9 49 92.4 44 61.2 Terminase large subunit
Conserved protein 16.2 50 93.9 45 16.3 Conserved protein
Portal protein 86.8 51 91.2 46 86.8 Portal protein
Conserved protein 34.0 52 77.6 47 34.6 Conserved protein
Conserved protein 11.8 53 15.1 48 12.1 Conserved protein
CsrA-like regulator 6.6 54 90.6 49 6.6 CsrA-like regulator
Major capsid protein 40.2 55 92.9 50 40.3 Major capsid protein
Conserved, virion associated 16.2 56 59.7 51 15.2 Conserved, virion associated
Conserved protein 22.7 57 78.9 52 22.1 Conserved protein
Conserved, virion associated 21.7 58 71.4 53 23.8 Conserved, virion associated
Conserved protein 23.7 59 87.8 54 23.9 Conserved protein
Continued on following page
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style. Of phages that have been characterized more extensively,
Bcep22 shares homology in eight of its proteins with temperate
coliphage 933W (AF125520) and Pseudomonas aeruginosa
phage F116 (AY625898). Phage 933W is a member of a closely
related group of temperate phages associated with enterohe-
morrhagic E. coli strains, including phages VT2-Sakai
(AP000363) and Stx2-converting phage 86 (AB255436). These
933W-like phages are themselves considered to be a subtype of
lambdoid phage (11). Phage F116, like Bcep22, is somewhat of
an “orphan” phage, bearing no clear relationship to other
sequenced phages (44). Gene arrangements between Bcep22
and these related organisms are mostly syntenic, with genes
encoding the terminase large subunit, portal, and major capsid
proteins remaining conserved in all four, which is not entirely
unexpected considering that these proteins must interact
closely during phage assembly.
Tail fiber genes. A striking feature of the Bcep22 and Bce-
pIL02 genomes is the presence of several tandemly repeated
copies of putative tail fiber genes. The genome of Bcep22
contains three copies of these genes (genes 64, 65, and 66),
whereas BcepIL02 contains four copies (genes 58, 59, 61, and
62) (Fig. 2). As shown in Fig. 3, all of these genes show peptide
TABLE 1—Continued
Phage Bcep22
% protein
identity
Phage BcepIL02
Putative function Calculated mass(kDa) Gene name Gene name
Calculated mass
(kDa) Putative function
Conserved, virion associated 14.3 60 66.7 55 14.8 Conserved, virion associated
Conserved, virion associated 26.0 61 37.3 56 30.1 Conserved, virion associated
Pectin lyase-like protein 72.5 62
Conserved, virion associated 9.9 63 45.4 57 10.1 Conserved, virion associated
Tail fiber 45.2 64 NAb 58 33.0 Tail fiber
Tail fiber 29.5 65 NAb 59 36.1 Tail fiber
60 18.9 Conserved protein
Tail fiber 30.8 66 NAb 61 29.5 Tail fiber
62 30.7 Tail fiber
Conserved, virion associated 62.5 67 92.2 63 62.9 Conserved, virion associated
Conserved, virion associated 12.5 68 69.5 64 12.7 Conserved, virion associated
Acyl-CoA N-acyltransferase 16.3 69 93.8 65 16.4 Acyl-CoA N-acyltransferase
Conserved, virion associated 35.2 70 88.8 66 35.1 Conserved, virion associated
PAPS reductase-like 27.6 73 93.6 67 27.3 PAPS reductase-like
68 23.1 Novel, virion associated
Conserved, virion associated 56.1 74 81.0 69 55.9 Conserved, virion associated
DarB-like antirestriction protein 496.4 75 87.9 70 503.9 DarB-like antirestriction protein
Conserved protein 8.7 76 97.5 71 8.6 Conserved protein
Possible antiholin 11.3 77 98.0 72 11.3 Possible antiholin
Holin 7.0 78 81.2 73 8.3 Holin
SAR endolysin 19.3 79 93.1 74 19.3 SAR endolysin
Rz-like lysis protein 18.4 80 47.8 75 18.5 Rz-like lysis protein
Rz1-like lysis protein 7.7 81 76 7.2 Rz1-like lysis protein
a Putative assignable functions and protein molecular masses are shown. Protein identities were calculated by the Dice method using BLASTp alignment identity
scores. OMP, outer membrane protein; SSB, single-stranded DNA-binding protein; CoA, coenzyme A; PAPS, phosphoadenylyl sulfate.
b NA, not applicable; the protein matched more than one protein in the other phage. See Fig. 3 and text for details.
FIG. 3. Dot plot comparisons of the predicted redundant tail fiber proteins from phages Bcep22 and BcepIL02. Note the conservation of the
N-terminal portions of these proteins and more-divergent C-terminal domains. The fine structures of the two repeat motifs present in five of the
seven described proteins are shown, using an enlargement of BcepIL02 gp58 as an example. In the first motif (top), four histidine pairs (HxH; bold)
are separated by partially conserved spacers (underlined); uppercase residues are conserved across all repeats in all five proteins. The second repeat
motif (bottom) is less well conserved; repeats conserved in BcepIL02 gp58 are underlined, residues conserved across all repeats are shown in
uppercase letters.
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sequence similarity to one another in their N-terminal domains
and various levels of similarity in their C-terminal domains,
suggesting that they arose from tandem gene duplications
within each phage, followed by divergence of their C-terminal
domains. Each phage appears to contain one “outlier” tail
protein (Bcep22 gp64 and BcepIL02 gp59) that is not related
in its C-terminal domain to any of the other tail fiber proteins
in either phage. These proteins, being the only significantly
diverged proteins among these putative tail fibers, may also be
the determinants that allow phage BcepIL02 to infect both
strain PC184 and AU1054 while limiting phage Bcep22 to its
own host, strain AU1054. The presence of the divergent tail
fibers may represent horizontal gene transfer events rather
than simple sequence divergence. All of these BcepIL02 and
Bcep22 putative tail fiber gene products show similarity in their
N-terminal domains to gp14 of Sinorhizobium meliloti phage
PBC5, which contains only a single copy of this gene. All of
these proteins except for Bcep22 gp64 and BcepIL02 gp59 also
have similarity, primarily in their C-terminal domains, to a
putative tail protein in Ralstonia phage RSL1 (YP_001950074),
a protein which also contains a phage tail collar domain
(IPR011083). Three of these proteins (Bcep22 gp66 and
BcepIL02 gp58 and gp62) contain detectable phage T4 gp12-
like receptor-binding domains in their C termini (SSF88874).
The T4 gp12 short tail fibers are responsible for the second,
irreversible step of phage adsorption to its E. coli host, recog-
nizing the core domain of bacterial lipopolysaccharide (64).
Of the five tail fiber proteins with C-terminal similarity
(Bcep22 gp65 and gp66 and BcepIL02 gp58, gp61, and gp62),
all contain two sets of conserved, tandemly repeating motifs in
their C-terminal domains, representatives of which are shown
in Fig. 3. One of the motifs present in each of these proteins is
a set of four histidine pairs (HxH), each separated by a 6-res-
idue spacer with the consensus sequence xVxDPx. Such HxH
pairs are known to be involved in the coordination of metal
ions in other phage tail fibers, such as T4 gp37 (2) and T4 gp12
(83). Their presence further supports the annotation of these
proteins as tail fibers and suggests that they may form rod-like
trimers, each trimer coordinating four metal ions. The other
repeating motif is a more degenerate, glycine- and serine-rich
region containing two to three 6- to 9-residue repeats. These
repeats are more highly conserved intragenically than they are
intergenically, with only the residues TGI conserved across all
TABLE 2. Proteins determined to be virion-associated by proteomic
analysis of CsCl-purified Bcep22 and BcepIL02 virionsa
Bcep22 %
identityc
BcepIL02
Putative function
Method(s)b Protein Protein Method(s)
G, W gp51 91.2 gp46 W Portal protein
G, W gp55 92.9 gp50 G, W Major capsid
protein
W gp56 59.7 gp51 G, W Conserved phage
protein
W gp58 71.4 gp53 G, W Conserved phage
protein
gp59 87.8 gp54 G, W Conserved phage
protein
gp60 66.7 gp55 G, W Conserved phage
protein
gp61 37.3 gp56 W Conserved phage
protein
G gp62 Pectin lyase-like
protein
gp58 G, W Tail fiber
gp59 G, W Tail fiber
gp60 G Conserved lectin-
like protein
G gp67 92.2 gp63 W Conserved phage
protein
gp68 69.5 gp64 W Conserved phage
protein
gp70 88.8 gp66 G, W Conserved phage
protein
gp68 W
G gp74 81.0 gp69 W Conserved phage
protein
G, W gp75 87.9 gp70 W DarB-like
antirestriction
protein
a Proteins listed in boldface were directly detected in the proteomic analysis,
while italicized protein names were inferred to be virion associated based on
their similarity to a protein directly detected in the other phage.
b The method used for detection: W, whole phage digest; G, gel slice digest.
c Dice similarity between pairs of BcepIL02 and Bcep22 proteins.
FIG. 4. Bcep22 proteins with detected homotypic interactions. Proteins are represented by white bars, which are shaded black in the regions
where one or more interacting protein domains were determined. Corresponding Bcep22 protein names and predicted functions are listed on the
left, and the number of clones recovered with inserts corresponding to each protein are listed on the right. All proteins are drawn to scale.
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repeats. The positions of these repeats near the C terminus of
each protein suggest that they may be involved in receptor
interaction, but no clear function for these tandem repeats can
be assigned currently.
While phages Bcep22 and BcepIL02 appear to contain mul-
tiple putative tail fiber protein orthologs, it is not clear how
these multiple genes may function as tail fibers in the mature
virion. The similarity of these proteins at the N terminus, which
is commonly the domain by which the phage tail fiber attaches
to the virion (45), suggests that all of these proteins are able to
associate with a common capsid domain. Assembly of two to
four different tail fiber proteins onto a single virion seems
highly improbable, given the asymmetries this would impose
on the virion’s structure and, presumably, its ability to adsorb
to the host cell. These genes are not arranged into any obvious
transcriptional unit that would allow selective expression of
single proteins in either phage, such as bounding by promoter/
terminator pairs or an invertible DNA segment like that found
in coliphage Mu (55). In the proteomic analysis of BcepIL02,
two of these putative fibers, gp58 and gp59, were detected
associated with the virion (Table 2), suggesting that at least two
of the four orthologous proteins in this phage are functional
and can participate in virion assembly. It is possible that de-
spite the expression of several tail fiber proteins, the phages
are able to exclusively assemble a single molecular species per
virion, giving rise perhaps to a heterogeneous population of
phages that are genetically identical but contain different tail
fiber species assembled onto the completed virion. Alterna-
tively, all proteins may be assembled together into a larger,
multiprotein tail fiber analogous to those produced by the
T-even phages, although this model seems less likely due to the
presence of the conserved N termini and diverged C termini of
these proteins and the lack of protein commonality between
the two phages. If these proteins were capable of forming
linearly ordered fiber structures, they would be expected to
measure on the order of 20 to 40 nm in length, based on
comparisons with the lengths of other phage tail fibers. How-
ever, no extended tail fibers were observed by transmission
electron microscopy, although their presence cannot be ruled
out definitively based solely on negative staining.
Mobile DNA and morons. The genome of Bcep22 contains
two free-standing HNH-type homing endonucleases, genes 15
and 16. These genes do not appear to be associated with
introns or inteins, as they do not interrupt any apparent coding
sequence, and the region containing these genes is flanked by
two complete and highly conserved genes: a serine tRNA gene
located 11 bp upstream of the start of Bcep22 gene 15, and
Bcep22 gene 17, which encodes a single-stranded DNA-bind-
ing protein and overlaps Bcep22 gene 16 by 1 base. The ge-
nome of Bcep22 also contains one putative IS element, which
contains Bcep22 genes 32, 33, and 34. The putative transposase
encoded by Bcep22 gene 32 is a member of the ISL3 family
(51). The IS element is bounded by imperfect inverted repeats
(IR) 24 bp in length with 5 mismatches; these repeats are
flanked by 8-bp direct repeats (see Fig. S1 in the supplemental
material). IR-L is located between genes 31 and 32 and over-
laps the C terminus of the predicted transposase by 10 bp.
IR-R is located between genes 34 and 35 in a predicted non-
coding region. The two other genes contained in this IS ele-
ment, 33 and 34, are conserved hypothetical genes. gp34 is
closely related to gp55 of Bcep781 and gp54 of Bcep43, both of
which are virulent phages that infect the related bacterium
Burkholderia cepacia (76).
BcepIL02 contains one putative moron, gene 22. This gene
is not present in Bcep22, whereas the genes immediately pre-
ceding and following it have homologs in Bcep22 (genes 28 and
29). Morons (or “more DNA”) are horizontally acquired genes
that are usually expressed while in the prophage state, presum-
ably providing some fitness advantage to the lysogenized host
(32). gp22 possesses weak (E, 0.02) similarity to the PagP
homologs of Bordetella parapertussis (NP_885888), Bordetella
pertussis (NP_881581), and Bordetella bronchiseptica (NP_890716)
and has an outer membrane -barrel transmembrane domain
(IPR011250) and a PagP-like lipid A acylation domain
(IPR009746). In Salmonella, PagP adds a palmitate group to
the lipid A component of lipopolysaccharide, resulting in in-
creased resistance to cationic peptides (24). Such heptaacy-
lated lipid A has also been shown to reduce endotoxin-associ-
ated inflammation (81) and therefore could be considered
a virulence factor. The outer membrane localization of
BcepIL02 gp22 is further supported by the presence of an
N-terminal secretion signal and signal peptidase I cleavage site
between residues 19 and 20. The DNA sequence immediately
upstream of BcepIL02 22 was found to contain a potential
promoter signal [TTGCAA(N17)GATAAT(N8)G], with the
predicted transcript start located 27 bases upstream of the
translational start. The nearest rho-independent terminator
was detected immediately downstream of BcepIL02 gene 26
(Fig. 2), suggesting the 22 promoter initiates a transcript con-
taining genes 22 through 26. The presence of this gene in
BcepIL02 is remarkable, as the currently sequenced phages
and prophages of B. cenocepacia have been noted for their lack
of virulence factors (75). If BcepIL02 is actually a temperate
phage, the PagP-like gp22 would be one of the rare Burkhold-
eria phage-encoded proteins, along with BcepMu gp53 (77),
with a putative role in bacterial virulence.
DNA replication and packaging. In a comprehensive study
of phage DNA replication modules, Weigel and Seitz (88)
placed the DNA replication module of phage Bcep22 (puta-
tively spanning genes 10 to 28) in the “initiator-helicase
loader” type in their classification system. Phage Bcep22 gp27
is the putative replication initiator protein, exhibiting similarity
to several other annotated phage replication proteins, such as
that of Salmonella phage Gifsy-1 (AAX65107) and containing
a DNA-binding Cdc6 domain (cd08768) associated with DNA
replication initiation. Bcep22 gp28 is a predicted DnaC-like
helicase loader, based on its similarity to other DnaC-like pro-
teins, such as that of the E. coli Rac prophage (NP_415878).
Phage BcepIL02 gp20 and gp21 are similar to these Bcep22 pro-
teins. Both Bcep22 and BcepIL02 also contain RecT/RecB-like
gene pairs (Bcep22 gp10/gp11 and BcepIL02 gp6/gp7) that may
possess recombination functions similar to exo and bet in co-
liphage lambda.
Bcep22 and BcepIL02 possess a similar (92.4%) termi-
nase large subunit (TerL) homolog, gp49 in Bcep22 and
gp44 in BcepIL02. These proteins are most closely related to
the terL homologs found in Pseudomonas aeruginosa phage
F116 (YP_164303) and Sinorhizobium meliloti phage PBC5
(NP_542306). Casjens et al. (12) found that although the Bcep22
and PBC5 TerL homologs could not be grouped conclusively with
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other phage terminases with well-studied packaging mechanisms,
their similarity to the terminase of phage T4 was suggestive of a
headful mechanism. The closest-studied TerL homolog to this
group is that of E. coli phage 933W (NP_049511), which appears
to package its genome by a headful mechanism initiated from a
diffuse packaging start site, producing terminally redundant, cir-
cularly permuted genomic DNA (62). Restriction digests of
BcepIL02 genomic DNA yield a circular restriction map (data not
shown), suggesting that DNA packaging in the phage is also
initiated from a diffuse site and is circularly permuted, as expected
for a headful mechanism.
The terminase small-subunit (TerS) homologs of Bcep22
and BcepIL02 were identified based on their homology to
other annotated small-subunit terminases, such as that of
phage F116 (YP_164302), and by the presence of a conserved
terminase small-subunit domain (IPR005335). The genes en-
coding the putative TerS proteins of phages Bcep22 and
BcepIL02 are located some distance away from their corre-
sponding terL genes (Fig. 2). This arrangement is somewhat
unusual, as terS genes are typically found adjacent to their terL
counterparts, as described for numerous lambdoid phage types
(11).
Lysis. Both phages Bcep22 and BcepIL02 contain closely
related lysis cassettes with the canonical gene order of holin-
endolysin-Rz/Rz1 (genes 78 to 81 and genes 73 to 76, respec-
tively). In both phages, the lysis genes appear to be arranged as
part of a divergent transcriptional unit, with two conserved
hypothetical genes upstream on the opposite strand (Bcep22
genes 76 and 77; BcepIL02 genes 71 and 72), bounded by
rho-independent terminators (Fig. 2). The holins exhibit class
II topology (two transmembrane domains, N-in, C-in) (87).
Although the holin genes do not have a dual start motif, which
in many phages allows the production of both holin and anti-
holin proteins from the same cistron, the smaller of the diver-
gently transcribed genes in this cluster has a single transmem-
brane domain and thus might serve as an antiholin.
Phages Bcep22 and BcepIL02 encode endolysins, detected
as N-acetylmuramoylhydrolase lysozymes (EC 3.2.1.17) of the
same class as the soluble lysozyme found in phage T4, which
contains a conserved EX8D/CX5T motif. However, the Bcep22
and BcepIL02 endolysins contain a motif of EX6EX5DX2T,
with two potentially catalytic Glu residues, neither of which are
located at the 	8 position from the Asp, and an atypically
short spacing between the Asp and Thr residues. It is therefore
difficult to determine which of these Glu residues might par-
ticipate in the catalytic cleavage of peptidoglycan, but based on
sequence alignments of the proteins with other known
lysozymes, the first of the two residues appears to be the most
likely possibility. Both the Bcep22 and BcepIL02 endolysins
also contain unambiguous SAR (signal anchor release) do-
mains. Endolysins with SAR domains are exported by the sec
system and accumulate as enzymatically inactive periplasmic
proteins tethered to the bilayer by the SAR domain (90). The
presence of a SAR endolysin makes it possible that the
Bcep22/BcepIL02 holins are pinholins, a class of holins that act
by depolarizing the membrane rather than forming holes large
enough to allow release of the endolysin, as in the case of
canonical holins (59, 60). Unlike the SAR endolysin of phage
P1, which utilizes cysteine isomerization for activation of the
enzyme (89), the SAR endolysins of Bcep22 and BcepIL02
contain no cysteine residues in their SAR domains, suggesting
that they are instead regulated by conformational changes as-
sociated with protein release from the bilayer (79). The final
step in phage lysis, disruption of the outer membrane, is ac-
complished by the spanin protein (7, 74). Most phages encode
two spanin subunits, the functional equivalents of the co-
liphage lambda Rz and Rz1 proteins. The Rz1 homologs of
phages Bcep22 and BcepIL02, gp81 and gp76, respectively,
belong to the embedded class of Rz1 genes, in that the entire
Rz1-equivalent reading frame is embedded in the 1 reading
frame of the Rz equivalent.
P1 DarB homologs. Bcep22 and BcepIL02 encode strikingly
large virion-associated proteins, gp75 (4,602 amino acids [aa])
and gp70 (4,667 aa), respectively (Tables 1 and 2), encoded by
genes that occupy over 20% of the phage genomes. Based on
sequence similarity and the presence and order of protein
functional domains, these proteins appear to be functional
equivalents of the 2,255-aa phage P1 DarB protein
(YP_006479). In E. coli, P1 DarB is required for protecting P1
DNA from restriction by the host type I restriction system.
Complementation analysis indicated that DarB operates only
in cis, suggesting that it may bind to or modify the cognate
phage DNA during or shortly after its ejection into the host
cell (31). Like Bcep22 gp75 and BcepIL02 gp70, P1 DarB is
virion associated (31) and contains a methyltransferase domain
followed by a DExH helicase domain (see Fig. S2 in the sup-
plemental material). It is not clear based on our analysis
whether these virion-associated DarB-like proteins interact
with DNA or RNA, but the association of these proteins with
protection of DNA from host restriction would imply a pro-
tein-DNA interaction. In P1, darB function is dependent on
darA, which is believed to possess a chaperone function for
assembly of DarB into the virion (30). No darA homolog was
detected in either BcepIL02 or Bcep22.
In addition to being considerably larger than P1 DarB, both
gp75 and gp70 contain an N-terminal soluble lytic transglyco-
sylase (SLT) domain that is absent from all other DarB-like
proteins identified. A number of podophages, including P22,
SP6, and K1-5 (53), and phage T7 (54) have been determined
to carry virion-associated proteins that possess muralytic activity.
During analysis of Bcep22 gp75, BcepIL02 gp70, and P1
DarB, it became apparent that this type of large, multidomain
helicase/methyltransferase protein is widely distributed across
a variety of bacteria. Because the P1 darB and its Bcep22 and
BcepIL02 homologs are located in phage genomes, the
genomic contexts of other DarB-like genes were of interest.
Using P1 DarB as the query sequence, 312 proteins greater
than 1,500 amino acids in length were identified in the NCBI nr
database at E values of 10	5. Of these, 206 were located in
the chromosomal sequences of incomplete or draft bacterial
genomes and were excluded from further analysis, except for
proteins in draft genomes unambiguously annotated as plas-
mids, which were retained. The resulting final collection con-
tained 106 P1 DarB-like proteins. All of these were found to
contain at least one methyltransferase domain (IPR002296,
IPR006935, IPR013216, IPR002052, IPR011639, or SSF53335)
and at least one helicase domain (IPR000330, IPR001650,
IPR014021, or IPR014001), suggesting that these proteins pro-
vide some function similar to that provided by P1 DarB, pos-
sibly protection from host restriction by DNA methylation
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(47). Interestingly, the large majority of these proteins, 84%,
could be found associated with some form of mobile DNA
element: 54 (51%) were located in plasmids, 29 (27%) were
located within previously described chromosomal mobile
DNA elements (variously documented as conjugative trans-
posons, insertion sequences, integrative conjugative ele-
ments, or genomic islands), and 6 (6%) were located in
bacteriophage genomes. A selected subset of these P1 DarB
homologs is shown in Table 3, and a complete listing of all
106 proteins is presented in Table S3 of the supplemental
TABLE 3. Selected homologs of the E. coli phage P1 DarB protein (YP_006479) and their genomic contexts, illustrating the association of
these proteins with mobile DNA elementsa
Source organism E-value(vs. P1 darB) Accession no.
Protein
length
(aa)
Taxonomic class Gene location Reference
Agrobacterium tumefaciens
MAFF301001
1.9E	14 NP_053287 1,693 Alphaproteobacteria Plasmid pTi-SAKURA
Agrobacterium tumefaciens C58 2.0E	15 NP_396621 1,693 Alphaproteobacteria Plasmid Ti 20
Bacillus cereus 03BB108 3.2E	20 ZP_03115564 2,366 Bacilli Plasmid p03BB108_86
Bacteroides fragilis YCH46 2.5E	12 YP_097425 1,938 Bacteroidetes Conjugative transposon
CTnYCH46-1
39
Burkholderia phage Bcep22 1.6E	14 NP_944303 4,602 Betaproteobacteria Bacteriophage genome
Burkholderia phage BcepIL02 1.2E	14 YP_002922742 4,667 Betaproteobacteria Bacteriophage genome
Burkholderia vietnamiensis G4 1.9E	132 YP_001109674 2,273 Betaproteobacteria Plasmid pBVIE05
Burkholderia vietnamiensis G4 1.5E	15 YP_001109960 1,853 Betaproteobacteria Plasmid pBVIE04
Campylobacter coli 1.2E	11 YP_063409 1,932 Epsilonproteobacteria Plasmid pCC31
Campylobacter coli RM2228 9.2E	11 ZP_00371038 1,854 Epsilonproteobacteria Plasmid pCC178
Campylobacter jejuni subsp. jejuni
81-176
6.6E	11 YP_247529 1,932 Epsilonproteobacteria Plasmid pTet
Clostridium difficile 630 1.6E	23 YP_001086891 2,907 Clostridia CTn2 conjugative transposon 69
Clostridium difficile 630 1.0E	22 YP_001088370 3,011 Clostridia CTn5 conjugative transposon 69
Enterococcus faecalis N03-0233 1.9E	24 ACQ89838 2,727 Bacilli VanG2 mobile element 8
Enterococcus faecalis T1 2.8E	17 ZP_05423918 2,266 Bacilli Plasmid unnamed
Enterococcus faecalis V583 4.2E	17 NP_815963 3,173 Bacilli vanB cassette (Tn1549-like) 61
Escherichia coli O111:H	 11128 0.0E 00 YP_003237917 2,255 Gammaproteobacteria Plasmid pO111_2 (P1-like
prophage)
58
Gordonia westfalica DSM44215 2.3E	11 NP_954816 1,630 Actinobacteria Plasmid pKB1
Helicobacter pylori Shi170 1.8E	14 ACF17793 2,609 Epsilonproteobacteria Putative conjugative
transposon plasticity zone
TnPZ
36
Leptospira phage LE1 4.8E	20 CAE14681 1,971 Spirochaetes Bacteriophage genome
Methylobacterium extorquens
DM4
2.5E	14 YP_003068159 1,698 Alphaproteobacteria dcm genomic island 86
Nocardia farcinica IFM 10152 7.3E	19 YP_121997 2,153 Actinobacteria Plasmid pNF1
Ochrobactrum intermedium LMG
3301
2.9E	15 ZP_04683497 3,526 Alphaproteobacteria Plasmid VBI00030_1
Rhodococcus equi 103 1.5E	14 NP_066779 3,229 Actinobacteria Plasmid p103
Rhodococcus equi PAM1126 1.1E	14 YP_002149612 2,949 Actinobacteria Plasmid pVAPA1037 46
Rhodococcus equi PAM1593 1.2E	14 YP_002149544 2,949 Actinobacteria Plasmid pVAPB1593 46
Rhodococcus erythropolis PR4 9.8E	16 YP_345073 2,936 Actinobacteria Plasmid pREC1
Rhodococcus opacus B4 1.5E	15 YP_002784492 2,889 Actinobacteria Plasmid pKNR
Sinorhizobium phage PBC5 3.4E	17 NP_542283 2,849 Alphaproteobacteria Bacteriophage genome
Streptococcus agalactiae 2603V/R 2.7E	16 NP_688280 2,274 Bacilli Putative conjugative
transposon
82
Streptococcus dysgalactiae subsp.
equisimilis NS3396
3.8E	16 ABV55437 2,278 Bacilli Conjugative element
ICESde3396
16
Streptococcus equi subsp. equi
4047
5.3E	23 YP_002746095 2,913 Bacilli ICESe1 27
Streptococcus equi subsp.
zooepidemicus
1.4E	16 YP_002745281 2,281 Bacilli ICESz2 27
Streptococcus pneumoniae ATCC
700669
6.4E	18 CAR69082 2,088 Bacilli Tn5252 transposon 15
Streptococcus pneumoniae
CGSP14
2.8E	17 YP_001836022 2,077 Bacilli Tn2008 17
Streptococcus pneumoniae G54 2.3E	16 YP_002037980 2,074 Bacilli Tn5253 18
Streptococcus suis GZ1 2.5E	20 ADE30961 2,554 Bacilli Acquired island region AI
33, antimicrobial
resistance
91
Vibrio sp. 0908 0.0E 00 YP_001595675 2,349 Gammaproteobacteria Plasmid p0908
Vibrio vulnificus YJ016 7.7E	18 NP_936882 4,392 Gammaproteobacteria 933W-like prophage element
a E values were obtained from BLASTp results for P1 DarB versus the NCBI nr database. References supporting the genomic context in chromosomally located DarB
homologs are provided.
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material. Some of the mobile DNA regions containing
DarB-like proteins are elements associated with important
virulence factors (e.g., Agrobacterium tumefaciens plasmid Ti
[20], Rhodococcus equi plasmid VapA1037 [46]), antibiotic
resistance (such as the Enterococcus faecalis vanB cassette
[61], or Streptococcus suis island AI 33 [91]), or phenotypic
conversion (Methylobacterium extorquens dichloromethane
utilization island dcm [86]).
Given the relatively large size of the proteins (ca. 1,500 to
4,600 amino acids) and their conserved domain structures, it
would appear that these P1 darB-like genes are not merely
hitchhiking DNA but provide some selective benefit to the
mobile elements with which they are associated. The most
likely mechanism of this benefit would be analogous to the
proposed function of P1 DarB, wherein the mobile DNA is
methylated during or shortly after transfer to a new cell in
order to protect it from host restriction. If so, this would make
these DarB-like proteins a novel class of widely distributed
antirestriction proteins, similar in effect (if not in mechanism)
to proteins such as ArdA, ArdB, and ArdC (4, 5, 13). The
presence of these proteins in phages, plasmids, and IS ele-
ments also highlights the potential for horizontal genetic trans-
fer, not only between phages (as has been well documented
[26]) but also between phages and other bacterial genetic ele-
ments.
Lifestyle of phages Bcep22 and BcepIL02. Phage BcepIL02
was initially reported as a potentially therapeutic phage, show-
ing efficacy against human pathogenic B. cepacia complex in a
mouse lung model (10). Based on the common criteria for
determining phage virulence, such as clear plaque morphology
and the inability to form stable lysogens, BcepIL02 is to all
outward appearances a virulent phage. Closer examination of
the phage genome and the interaction between the phage and
its host raised doubts about this classification. It has become
clear that phage virulence is not a characteristic that can always
be easily determined: a phage definitively can be proven as
temperate by its ability to form stable lysogens, but the absence
of stable lysogen formation is not necessarily diagnostic for
virulence.
(i) Genomic evidence for a temperate lifestyle. The genomes
of both Bcep22 and BcepIL02 encode predicted recombinases,
Bcep22 gp6 and BcepIL02 gp4. The presence of such recom-
binases in phage genomes is typically cited as indicative of a
temperate phage lifestyle, as proteins of this type often func-
tion as phage integrases. BcepIL02 encodes a predicted ty-
rosine recombinase, gp4. Based on BLASTp alignments to
its closest Caudovirales neighbors, the catalytic tyrosine of
BcepIL02 gp4 is predicted to be Y343 (corresponding to Y342
in lambda int), which is located 31 residues downstream from
the conserved HxxR motif and 9 residues downstream from a
conserved histidine residue, which correspond to lambda int
H308, R311, and H333, respectively (23). The 402-bp region
between genes 3 and 4 of the BcepIL02 genome was analyzed
for structural features characteristic of a potential tyrosine
recombinase-associated attP site. A 10-bp imperfect comple-
mentary repeat, separated by 11 bp, was found 172 bases up-
stream of the gene 4 start, colocalized with seven direct repeats
that may serve as arm sites for phage integrase binding (Fig.
5A). The structure of this region is analogous to the attP region
of phage lambda, which also utilizes a tyrosine recombinase for
integration.
In Bcep22, the putative serine recombinase gp6 is highly
related (60% identity) to a predicted serine recombinase gp53
(ABA60054; E 
 0) of phage Bcep176 (NC_007497), a known
functional temperate bacteriophage located within chromo-
some 2 of Burkholderia multivorans strain ATCC 17616
(AP009386; nucleotides 1620484 to 1665345). Based on the
arrangement of the Bcep176 prophage in strain 17616, the
gp53 recombinase is located 69 bp downstream from the pre-
dicted phage attP site and becomes the first gene at the ex-
treme left end of the prophage. This location is typical of
phage integrases in the prophage state and provides additional
support that this serine recombinase functions as a phage in-
tegrase in Bcep176 and, due to its high sequence similarity to
FIG. 5. The putative attP sites of phages BcepIL02 (A) and Bcep22 (B). (A) The 288 bp of DNA sequence upstream of BcepIL02 gene 4, a
predicted tyrosine recombinase. The 11-bp attP core site (labeled O) is written in bold and is flanked by the 10-bp imperfect complementary repeats
of P and P; complementary bases are underlined. This region was also found to contain seven 7- to 9-bp repeat motifs (shown boxed) with the
core common sequence TGCTAC, and are putative arm-type recombinase-binding sites. Five sites were found on the coding DNA strand and two
on the reverse strand; arrows below the boxes indicate arm site orientation. The final three bases of the displayed sequence are the start codon
of the recombinase gene 4. (B) The putative attP site of Bcep22. The 4-bp O core site (bold) is centered 126 bp upstream of the start of the
predicted Bcep22 serine recombinase gene 6 (data not shown). O is flanked by 8-bp perfect complementary repeats P and P; complementary bases
are underlined.
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Bcep22 gp6, is expected to provide the same function in
Bcep22. In the Bcep22 genome, a potential attP site is located
upstream of gene 6, comprised of a pair of perfect 8-bp com-
plementary repeats, spaced 4 bp apart (Fig. 5B). This pair of
phages represents an unusual example of phage modular evo-
lution, as Bcep22 has apparently substituted a serine recombi-
nase for the tyrosine recombinase found in BcepIL02 that is
typically associated with lambdoid phages.
Both phages Bcep22 and BcepIL02 also contain putative re-
pressor proteins, gp13 in Bcep22 and gp8 in BcepIL02 (Fig. 2;
Table 1), which may function as lysogenic repressors. Bcep22
gp13 contains an HTH, lambda-like DNA-binding domain at its
N terminus (IPR001387, IPR010982, CATH1.10.260.40) and was
also shown to dimerize via its C-terminal domain by homotypic
interaction analysis. BcepIL02 gp8 is overall 77% identical to
Bcep22 gp13 and 90% identical in its first 100 residues, the loca-
tion of the HTH domain, and also contains a detectable DNA-
binding domain (CATH1.10.260.40).
(ii) Phages Bcep22 and BcepIL02 are unable to form lyso-
gens. To examine the potential for lysogeny, 16 phage-insen-
sitive strains were isolated following challenge by phage
Bcep22 or BcepIL02. Phage BcepIL02 exhibited EOPs ranging
from 10	3 to 10	4 when plated on the BcepIL02-insensitive
mutants, whereas Bcep22 exhibited EOPs of 10	3 to 10	4 (n

2) or 10	6 (n 
 6) on the Bcep22-insensitive mutants. Ad-
ditionally, the three AU0728 strains isolated during in vivo
challenge (10) exhibited EOPs of ca. 10	4, compared to plating
on the wild-type stain. Culture supernatants of these insensi-
tive strains were plated against lawns of the parental wild-type
strains; none of the insensitive strains produced a phage capa-
ble of producing plaques on the wild-type parental strains,
suggesting that these strains are not insensitive due to lysogeny
but due to some other mechanism, such as resistance due to
the alteration of a phage receptor. One of the PC184-derived
insensitive strains was tested for its ability to adsorb phage
BcepIL02, and the phage adsorption rate was found to be
severely reduced compared to adsorption to the wild-type
strain (data not shown), suggesting insensitivity due to some
phage adsorption defect.
To further investigate the phage lifestyle, an alternative ex-
perimental approach was used to specifically examine the in-
teraction of phage BcepIL02 and its host PC184. This system
was examined because phage BcepIL02 already has been stud-
ied as a potentially therapeutic phage (10), and therefore its
status as a virulent phage is of greater immediate interest. High
MOI experiments were conducted by incubating cells of strain
PC184 with a large excess of phage and enumerating the bac-
terial survivors. It previously has been demonstrated that the
temperate coliphage lambda lysogenizes its host cell at a fre-
quency that is strongly dependent on the number of virions
adsorbed by a given cell, both in measurements of bulk culture
(38) and at the single-cell level (92). In bulk systems, infections
conducted at higher MOIs result in a greater frequency of
lysogen formation, approaching 100% of cells lysogenized as
the actual MOI reaches 5.
In the experiments reported here, after 30 min of incubation
of cells with phage at an input MOI of10, actual MOIs of 5.7
to 6.4 were achieved (Table 4). If BcepIL02 were a virulent
phage with no potential for becoming repressed during the
infection cycle, a single round of infection at a real MOI of 6
should result in a 1,000-fold reduction in CFU following chal-
lenge. As shown in Table 4, approximately 10 to 20% of the
cells survived phage exposure, 36- to 133-fold greater than
predicted. Twenty-four surviving colonies from these experi-
ments were isolated, subcultured, and tested for sensitivity to
the phage and phage production from culture supernatants as
described previously. All 24 isolates exhibited EOPs equivalent
to the wild-type strain, and none produced any detectable
phage in their culture supernatants, indicating that these
strains did not survive phage challenge due to either stable
lysogeny or mutation to resistance.
To interpret these results and reconcile them with the
genomic observations above, we propose that phage BcepIL02
and, by extension, Bcep22, may be temperate phages that are
unable to successfully integrate into the host chromosome.
Thus, repression can be established, thereby allowing a signif-
icant fraction of infected cells to survive, but stable prophages
cannot be formed. In this scheme, the unintegrated repressed
prophage is lost upon cell division. This situation may be anal-
ogous to the behavior of phage lambda int mutants, which are
able to form abortive lysogens that give rise to sensitive cells
upon subculture (19, 21). In a study of a known temperate B.
cenocepacia phage, KS9, only 18% of the phage-insensitive
strains isolated following phage challenge were true lysogens,
the remainder becoming insensitive presumably by some other
mechanism (49). Phages Bcep22 and BcepIL02 may be a more
extreme version of this behavior, in which lysogen formation, if
it occurs, is below the rate of bacterial mutation to phage
insensitivity. The predicted attP O sites of both Bcep22 and
BcepIL02 are not found in the genomes of the hosts used to
isolate them (AU1054 and PC184, respectively). In Bcep22,
regions that exactly match the predicted attP site were located
in Burkholderia vietnamensis G4 chromosome 3 (CP000616;
positions 203779 to 203799) and also Edwardsiella tarda
(CP002154; positions 1524102 to 1524127), suggesting that the
natural lysogenic hosts of these phages may not be B. cenoce-
pacia at all but instead other soil microorganisms.
Conclusions. Due to frequent horizontal gene transfer and
the mosaic nature of phage genomes, bacteriophages pose a
major challenge to meaningful taxonomy. Phage morphology,
a long-standing taxonomic criterion, is of limited usefulness in
this regard, prominently exemplified by the relatedness of
lambda, a siphophage, and P22, a podophage. A functional
taxonomic approach, focusing on protein similarity, has pro-
duced some biologically meaningful classification of podophages
(43) and myophages (44). This method, however, has thus far
remained confined to comparisons of phages within a given
TABLE 4. Actual MOI and calculated and actual bacterial
survivors of B. cenocepacia strain PC184 following
exposure to phage BcepIL02a
Replicate
no.
Actual
MOI
Predicted %
surviving
cells
Measured %
surviving
cells
Fold excess of
survivors vs.
prediction
1 5.7 0.32 11.7 36
2 6.3 0.19 17.6 94
3 6.4 0.16 21.3 133
a Predicted survivors were calculated from the Poisson distribution for the
measured actual MOIs. Results of three replicate experiments are shown.
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morphotype and has not thoroughly examined intermorpho-
type relationships. A useful grouping, “phage type,” has been
advanced by Casjens (11), based on sequence similarity of
individual proteins in addition to similarities in genome size,
gene order, and transcriptional pattern, irrespective of phage
morphology. Using the direct criteria of protein similarity,
phages Bcep22 and BcepIL02 form a novel phage group with
no evident relationships to other phages. Using the phage type
system, these phages can be seen to share some characteristics
with the lambdoid phages, such as the organization of the
DNA replication genes and the similarity of the TerL, portal,
and major capsid proteins to those of the lambdoid phage
933W. Even under these expanded criteria, however, these
phages lack significant relationships to any other characterized
phages and are characterized instead by physically uncoupled
terS/terL gene pairs, unusual clusters of tail fiber orthologs, and
the presence of a unique DarB-like protein with an N-terminal
SLT domain. Due to their inability to form lysogens in the
hosts used here, it is not clear if these phages are temperate,
but their genome organization and behavior when infected
under high-MOI conditions strongly suggest that they are tem-
perate phages. The fact that BcepIL02 was able to produce
significant treatment effects in the mouse lung model (10) may
be due to its behavior as a de facto virulent phage in at least
certain strains, unable to give rise to homoimmune lysogens in
the host population. Resurgent interest in the use of phages for
the treatment of bacterial infections, and the general consen-
sus that temperate phages are not optimal candidates for use in
phage therapy, has brought into focus the issue of determining
the lifestyle of novel phages as either temperate or virulent.
On the basis of simple experiments, such as plaque morphol-
ogy or the isolation of phage-insensitive strains, these phages
would appear to be virulent. Upon further experimentation
and genomic analysis, however, these phages exhibit all the
hallmarks of temperate phages, save for their ability to pro-
duce stable lysogens. The behavior of BcepIL02 is a topic
deserving of further study as a means to define the working
criteria for virulence and temperance in the context of phage
therapy.
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